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ABSTRACT 
USA300, a strain of community-associated methicillin resistant Staphylococcus 
aureus (CA-MRSA), has become prevalent in the community. Colonization of human skin 
requires mechanisms that allow this bacterium to overcome the innate immune defenses on 
the skin, including secretion of antimicrobial lipids. Antimicrobial lipids inhibit S. aureus 
growth and induce the staphylococcal proteolytic cascade, producing aureolysin (Aur) which 
processes the lipase glycerol ester hydrolase (Geh). Nearly all S. aureus strains secrete Geh, 
yet little information exists concerning its function. Using purified Aur and Geh we confirm 
that aureolysin processes proGeh to Geh. We then confirmed that geh was required for lipase 
activity and both forms of the purified enzyme had lipase activity. Finally we showed that 
optimal growth in trilinolein requires Aur, and might reflect a requirement for the proGeh 
form of the enzyme to convert trilinolein into toxic linoleic acid, despite that fact that both 
unprocessed and processed Geh catalyze the hydrolysis of trilinolein.  
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INTRODUCTION 
1.1 Staphylococcus aureus 
 
1.1.1 Description 
Staphylococcus aureus is a Gram-positive bacterium where the individual cocci 
divide in two planes resulting in the formation of grape like clusters, and for this reason the 
word Staphylococcus is derived from the Greek term staphylé (“bunches of grapes”). S. 
aureus is the most pathogenic of the staphylococci and was identified in the 19
th
 century. S. 
aureus strains are characterized by a golden-yellow pigment, staphyloxanthin (aureus: 
“golden”). Additionally, S. aureus are the only staphylococci with the ability to produce the 
protein coagulase which allows for the conversion of fibrinogen to fibrin, allowing fibrin to 
coat the bacteria and thus protecting them from attacking host cells (59). S. aureus is a highly 
persistent organism which can survive  in high salt conditions (up to 15 % NaCl),  dry 
environments and can survive over a wide pH range from 4.8 to 9.4 (15, 58). These survival 
mechanisms allow it to thrive in many harsh environments, ranging from the surfaces of 
medical equipment to the epidermal and mucosal layer of mammals.  
 
1.1.2 S. aureus and Virulence 
Staphylococcus aureus is a human commensal bacterium found to persistently 
colonize about 30% of the human population (73). While the organism is generally harmless 
to healthy individuals, S. aureus is a significant opportunistic pathogen and is the causative 
agent in over 10% of all nosocomial bacterial infections in the United States (25). 
Furthermore S. aureus infection can range from mild skin and soft tissue infections to more 
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severe conditions such as necrotizing pneumonia, osteomyelitis, toxic shock syndrome, 
bacteremia and infective endocarditis (56).  
Virulence factors provide bacteria with mechanisms that aid in their in vivo growth 
and enhance their ability to cause disease. S. aureus possesses a vast array of virulence 
factors which contribute to its success as a pathogen. S. aureus possesses a plethora of 
surface-associated virulence factors which aid in adherence followed by the establishment of 
infection (15). Furthermore, some of these surface-associated proteins also provide an 
immune evasion mechanism by modulating the host immune response. Cell surface virulence 
factors can include cell wall anchored proteins or polysaccharides. Polysaccharides such as 
teichoic acid on the S. aureus cell wall aid in adhesion to endothelial surfaces while other cell 
surface components such as peptidoglycan and lipoteichoic acids can cause neutrophil 
infiltration and septic shock (45, 50, 95, 96). S. aureus also produces several pore forming 
toxins which create pores in the cell membrane resulting in lysis through osmotic imbalance. 
Two of these pore forming toxins are known as α-toxin and β-toxin which are capable of 
destroying erythrocytes (15). Destruction of erythrocytes is a key nutritional strategy that 
provides S. aureus with a source of heme-iron for uptake. Additionally S. aureus secretes a 
variety of toxins and exoenzymes capable of causing damage to host tissue.  For example, S. 
aureus produces the toxic shock syndrome toxin-1 (TSST-1), a known superantigen, which 
through the activation of T cells induce a massive cytokine storm resulting in fevers, rashes, 
hypotension, multi-organ failure and death (15, 92). Exoenzymes such as proteases, lipases 
and nucleases are some of the less well-understood virulence factors of S. aureus, and the 
relevance of both proteases and lipases will be further explored throughout this study. 
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1.1.3 Methicillin Resistant Staphylococcus aureus 
 Administration of penicillin was the effective traditional treatment for S. aureus 
infections and could significantly reduce mortality rates in patients (27). However, due to the 
use of penicillin, antibiotic-resistant strains of S. aureus emerged and widespread penicillin 
resistance around the world had occurred by the 1950s (15).  Even with the development of 
next generation antibiotics, both resistant hospital-acquired and community-acquired strains 
emerged. The emergence of resistance to beta-lactam antibiotics such as cephalosporins, 
carbapenems, cephamycins and monobactams prompted development of methicillin. 
Unfortunately, by 1961, just 2 years since the introduction of the drug to penicillin resistant 
S. aureus, the first methicillin resistant S. aureus (MRSA) were reported. Over the next 
several decades MRSA spread around the world, and is now endemic in most healthcare 
facilities in developed countries. Methicillin and beta-lactam class antibiotic resistance is 
encoded on a genomic island called the staphylococcal cassette chromosome mec (SCCmec), 
which also encodes tetracycline resistance (38).  A major concern is the increase of multidrug 
resistant strains of MRSA, which have evolved resistance to other classes of antibiotics 
including rifampin, fluoroquinolones, aminoglycosides, tetracyclines and chloramphenicol. 
Additionally, the emergence of MRSA strains resistant to vancomycin, the treatment of last 
resort for some MRSA strains, leaves the possibility of emerging S. aureus infections that 
would be untreatable with current antibiotics (16, 27).  
 In contrast to healthcare-associated MRSA (HA-MRSA), which often infect 
individuals who are at high risk or already ill, community-associated MRSA (CA-MRSA) 
strains can infect healthy individuals. This, in combination with the unusually severe disease 
caused by these strains, suggests that CA-MRSA possess greater virulence potential than 
traditional strains (16). CA-MRSA is transmitted by direct contact, usually skin-to-skin, with 
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an infected individual and this often occurs among military settings, locker rooms and among 
children in daycare centers where there is a combination of close body contact and low 
personal hygiene. In particular the CA-MRSA strain USA300 has become a leading cause of 
visits to hospital emergency departments as it is easily transferred to household contacts 
compared to other S. aureus strains (24, 63). 
 
1.1.4 USA300 
The USA300 strain is a particularly hypervirulent strain of CA-MRSA which has 
become endemic within the community. USA300 clones show a high level of genetic 
similarity, with different isolates being distinguished only by a few single nucleotide 
polymorphisms (71). In a brief time span this strain has become the most frequent cause of 
skin and soft tissue infections in emergency rooms in the United States, being responsible for 
97% of MRSA and 58% of all reported skin infections (67). Since the appearance of USA300 
the percentage of MRSA carriers has doubled (31). It can be inferred that the increased 
incidence of USA300 infections can, in part, be attributed to an increased frequency of 
colonization. 
In addition to its exceptional transmission and colonization from host to host, the 
USA300 strain has been associated with highly invasive diseases such as necrotizing 
pneumonia, severe septicaemia and necrotizing fasciitis (28, 30, 64). USA300 was found to 
be more resistant to killing by human polymorphononuclear leukocytes and more effective at 
causing host cell lysis. Mouse bacteraemia models show that it is significantly more virulent 
than other MRSA strains and is more highly invasive of major organs (94). 
 Like other CA-MRSA, USA300 carries the type IV SCCmec cassette, which lacks 
additional resistance genes other than mecA, thereby eliminating the fitness cost imposed by 
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this cassette when there is a lack of antibiotic stress (19). However, the extraordinary success 
of USA300 as a pathogen and its ability to overtake other CA-MRSA clones can be 
attributed to the presence of unique genetic elements that enhance colonization and 
transmission. Exclusive to the USA300 strain is the 31-kb arginine catabolic mobile element 
(ACME) (Figure 1) which is a putative pathogenicity island found adjacent to SCCmec (19). 
In USA300, ACME is thought have been acquired from S. epidermidis, likely through 
horizontal gene transfer. However, ACME has also been identified among other coagulase-
negative staphylococci (CoNS) such as S. haemolyticus and S. capitis in which it has a more 
genetically diverse organization than in S. aureus (83). ACME encodes two major gene 
clusters which include an arginine deiminase (arc), a spermine/spermidine acetyl-transferase 
(speG) and oligopeptide permease (opp) operon, both of which are homologs of genes that 
are accepted virulence factors (18). 
Most pathogens often have difficulty colonizing the harsh environment of the human 
skin, yet USA300 is able to colonize this niche at a higher rate than other strains. One 
attribute of skin that deters infections is the acidic pH (4.2-5.9). However, the presence of 
Arc encoded by ACME has been found to enhance the acid tolerance of USA300, including 
to, for example, exogenous lactic acid, the major organic acid present on human skin (1, 62, 
93). The ACME Arc encoded arginine deiminase pathway converts L-arginine to carbon 
dioxide, ATP and ammonia, which counteracts the acidity of the environment (18, 19, 66, 83, 
93). 
Polyamines are aliphatic compounds produced by many organisms that exert a variety 
of effects on cellular physiology. Polyamines include putrescine, spermidine and spermine  
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Figure 1. The Arginine mobile genetic element. The 31-kb ACME is unique to the 
USA300 strain of S. aureus and is thought to confer upon this strain an enhanced ability to 
colonize the human skin.  
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and are all compounds synthesized from L-arginine. However, S. aureus is unable to produce 
polyamines and exogenous polyamines actually inhibit S. aureus growth, and are bactericidal 
at concentrations found in humans. USA300 is a notable exception in that it exhibits 
complete resistance to high levels of exogenous polyamines due to the presence of a 
spermine/spermidine acetyl-transferase system encoded on ACME (41).  
Additionally ACME encodes a putative oligopeptide permease operon, Opp-3. Opp 
operons in Gram-positive and Gram-negative bacteria possess a range of functions including 
peptide uptake, quorum sensing, chemotaxis, binding of serum components and expression of 
virulence determinants (74). In vivo models have shown that disruption of Opp-1 and Opp-2, 
which are found on the core genome have been shown to result in major growth defects and 
attenuated virulence (12).  
USA300 also possesses several other newly acquired genes such as the enterotoxin K 
and Q (sek2 and seq2) in the unique SaPI5 pathogenicity island, and these contribute to 
pathogenesis by binding T-cells (18).  USA300 also possesses Panton-Valentine leukocidin 
(PVL), a pore forming toxin which causes necrosis and apoptosis in leukocytes. PVL is a bi-
component toxin encoded by the lukS-PV and lukF-PV genes (12). Furthermore, research 
indicates a high level of correlation between the production of PVL and severe skin and soft 
tissue infections, necrotizing pneumonia and fasciitis (14, 29). Levels of PVL sufficient to 
result in rapid neutrophil lysis can be directly detected in abscesses on human skin (4, 5). In 
rabbit models, USA300 strains lacking PVL displayed attenuated virulence in pneumonia, 
osteomyelitis and skin abscess models (13, 17, 48). Additionally, the expression of several 
virulence genes such as α-toxin (Hla), a potent pore forming toxin, δ-toxin (hld) and α-type 
phenol soluble modulin (PSMs) is also elevated in the USA300 strain (7, 40, 53). 
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Consequently, the success of USA300 as a pathogen can be attributed to the amalgamation of 
an array of factors. 
 
1.2 Lipids 
 
1.2.1 Chemical and Physical Properties of Lipids 
Lipids are an integral part of the physiology and pathophysiology of biological 
systems. Although there is no widely accepted definition of the term lipid, a broad definition 
would be that lipids are hydrophobic or amphipathic molecules that are created either entirely 
or partly from carbanion-based condensations of thioesters or by carbocation-based 
condensations of isoprene units (26). Although there are several categorization systems for 
lipids (Table 1), they can broadly be classified as “simple” and “complex” lipids. Simple 
lipids yield two products upon hydrolysis while complex lipids yield three or more products. 
A lipid is saturated if all available spaces where hydrogen bonding to carbon can occur are 
occupied, while an unsaturated lipid has at least one double bond between carbon atoms. As 
a result, unsaturated lipids tend to have lower melting points and are more vulnerable to lipid 
peroxidation (51).  In this study we will focus on free fatty acids and triglycerides such as 
those seen in Figure 2. 
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Table 1. Lipid categories 
Category Example 
Fatty acyls dodecanoic acid 
Glycerolipids 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol 
Glycerophospholipids 
1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine 
Sphingolipids N-(tetradecanoyl)-sphing-4-enine 
Sterol lipids cholest-5-en-3β-ol 
Prenol lipids 2E,6E-farnesol 
Saccharolipids 
UDP-3-O-(3R-hydroxy-tetradecanoyl)-αD-N-
acetylglucosamine 
Polyketides aflatoxin B1 
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A      B 
              
 
Figure 2. Structures of lipids. A) Linoleic acid and B) trilinolein which is composed of 
three linoleic acid molecules esterified to a glycerol backbone. 
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1.2.2 Biological Role of Lipids  
Lipids have several important roles in biological systems, which include energy 
storage, signaling, and as one of the structural components of the membrane (26, 90). The 
biological membrane is essentially a lipid bilayer, the formation of which is energetically 
favoured when glycerophospholipids are put in an aqueous environment, arranging 
themselves so that the polar head groups face the aqueous side and the hydrophobic fatty acid 
tails face each other (97). Recently, it has been shown that lipid signaling is important for 
communication in cells. Some of these signaling lipids are involved in regulation of cell 
growth, apoptosis, protein activation, and calcium mobilization (36, 80). One of the most 
important and well understood functions of lipids is for energy storage in animals and plants, 
especially in the form of triglycerides (8).  
 
1.2.3 Lipids in Infection and Immunity 
The sebaceous glands on the skin secrete several factors that are growth inhibitory to 
many invading pathogens. An innate immune mechanism used to hinder bacterial persistence 
is the secretion of sebum (65, 98), a liquid concoction of lipids composed of 28% free fatty 
acids, 32% triglycerides, 25% wax esters and 11% squalene (88). Sapienic acid (C16:1Δ6), is 
the major constituent of sebum triglycerides and fatty acids (98), and S. aureus is also 
significantly exposed to linoleic acid (C18:2) from nasal secretions, during colonization of 
the anterior nares (20). Previous studies have shown that at physiological concentrations, 
linoleic acid (50 μM) is inhibitory to the growth of USA300 and results in an extended 12 
hour lag phase in vitro (2). Fatty acids have been reported to interfere with cell growth by 
altering cell permeability, uncoupling oxidative phosphorylation or by blocking electron 
transport (9, 10, 33, 35, 46, 47, 87).  
13 
 
 
 
Generally lipid extracts from animal and microbial sources contain roughly 60 to 80% 
phosphates and glycolipids with the remainder consisting of neutral lipids (44). However 
lipid extracts from staphylococcal abscess homogenates revealed the composition to be 90% 
neutral lipids and 10% glycolipids and phosphatides, and of the neutral lipids about 40% 
were free fatty acids, including linoleic acid which is found to accumulate to high levels in 
tissue abscesses which are characteristic of S. aureus skin and soft tissue infection (22). This 
raises the question of how S. aureus can colonize and persist on human skin, mucosal 
membranes, and within abscesses, despite the abundance of antimicrobial lipids such as free 
fatty acids, monoglycerides and triglycerides, found in these environments (55). 
 
1.2.4 Resistance to Antimicrobial Fatty Acids 
While some bacteria can use fatty acids as a means of energy, this only occurs when the 
fatty acid is broken down into two-carbon acetyl-CoA molecules through the β-oxidation 
process so that they can enter the TCA cycle. However, S. aureus lacks the enzyme required 
for β-oxidation (18, 72) and consequently is unlikely to have the ability to break down fatty 
acids in this way. In addition to using fatty acid for energy, some bacteria secrete fatty acids 
such as linoleic acid. For example, Lactobacilli which are a part of the nasal microbiota, 
secrete linoleic acid, which has been shown to inhibit S. aureus growth (2). Since S. aureus is 
also part of this niche, it competes with the nasal microbiota for colonization, including 
several bacterial phyla such as Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria. 
Evidence of bacterial competition was seen from studies indicating an inverse correlation 
between the members of Actinobacteria family and the amount of Staphylococcacaece 
present (52). Differences in the fatty acid profile of nasal secretions may be dependent on the 
profile of microbiota found in different individuals. 
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One proposed mechanism of fatty acid resistance is the Fatty Acid Modifying 
Enzyme (FAME). It has been shown that S. aureus uses FAME, an extracellular enzyme, to 
counteract the staphylocidal activity of free fatty acids and monoglycerides
 
and has been 
detected in 80% of S. aureus strains (55). Contrary to typical lipases, FAME has been shown 
to have optimal activity at a pH ranging from 5.5 to 6.0, which is similar to the acidic pH of 
human skin, which can range from pH 4.2 to 5.9 (18, 42). When fatty acids were incubated 
with FAME in the presence of ethanol or cholesterol, fatty acid esters were produced. Thus 
FAME acts by esterifying free fatty acids directly or transferring the acyl group of 
monoglycerides to short chain alcohols and cholesterol (57). While FAME has been detected 
experimentally, neither the FAME protein nor its corresponding gene has yet been identified 
(18, 42, 68). Interestingly, staphylococcal FAME is strongly inhibited by triglycerides, which 
are found in large pools in abscesses.  However, studies show that all strains with FAME 
activity also exhibit lipase activity. In order to evade the issue of FAME inhibition, it is 
believed that S. aureus employs a lipase which releases the fatty acids from their glyceride 
backbone so that FAME can esterify the free fatty acids (55). In murine models, strains 
possessing FAME activity exhibit greater virulence than strains in which FAME has not been 
detected (68). 
Other suggested mechanisms of fatty acid resistance implicate a cell wall component 
as a requirement for fatty acid resistance. This hypothesis is based on literature suggesting 
that the lack of a cell wall anchored component causes increasing sensitivity to fatty acids. 
Some of the components implicated include teichoic acids, surface protein G (SasG) and the 
heme coordinating surface protein IsdA (11). While the exact mechanism by which these 
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elements confer resistance has yet to be established, the implication is that they prevent fatty 
acids from seeping into the cell by acting as a barrier. 
 
1.3 Staphylococcal Proteases 
 
1.3.1 Proteases 
 Proteases are enzymes, which induce protein catabolism by hydrolyzing the peptide 
bonds that hold together the amino acids that form a polypeptide. Studies have shown that 
staphylococcal proteases are also key virulence determinants, as they have been known to 
cleave and degrade a variety of important host proteins including elastin, plasma proteinase 
inhibitor and the heavy chains of all human immunoglobulin classes (75-78). Furthermore, 
more recent studies suggest that proteases may be involved in the conversion of S. aureus 
from an adhesive to invasive state through the degradation of cell surface proteins such as 
fibronectin binding protein (43, 61, 79, 91).  
 
1.3.2 The Staphylococcal Proteolytic Cascade 
S. aureus encodes four major extracellular proteases, including a metalloproteinase 
(aureolysin, Aur), a serine glutamyl endopeptidase (serine protease, SspA) and two cysteine 
proteases, staphopain A (ScpA) and staphopain B (SspB) (3). SspA and SspB are co-
transcribed in the  sspABC operon, which also includes a third open reading frame sspC, 
encoding a cytoplasmic inhibitor of SspB (60). The Aur, SspA, and SspB proteases are 
expressed as proenzymes, which are subsequently activated in what is known as the 
Staphylococcal proteolytic cascade pathway, Figure 3 (2).  
16 
 
 
 
 
 
 
Figure 3. The staphylococcal proteolytic cascade. Induction of the straphylococcal 
proteolytic cascade results in the autocatalyzation of aureolysin to its mature form, which in 
turn results in the maturation of SspA and culminates with the activation of SspB.  
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 Aureolysin is a secreted protease of S. aureus belonging to the M4 metalloproteinase 
family of enzymes, which include a number of enzymes which are acknowledged virulence 
factors. Aureolysin cleaves several host proteins, including peptides involved in immune 
escape. In vitro experiments have shown that aureolysin cleaves some plasma proteinase 
inhibitors and activates prothrombin in human plasma (69).  
 Aureolysin is regulated by agr (accessory gene regulator) and sarA (Staphylococcal 
accessory regulator), both of which are known virulence regulators in S. aureus despite the 
lack of understanding on the importance of aureolysin in virulence. Transcription of 
extracellular proteases is generally repressed by sarA and stimulated by agr (54). The agr 
gene system results in production of RNA III, which stimulates the expression of several 
exoprotein genes. While the exact mechanism of RNA III dependent regulation is unknown, 
it is believed to interact with other regulatory proteins rather than direct binding to the 
promoter of target genes. During regulation of agr, RNA III is believed to neutralize a 
repressor of aur, the Rot protein expressed by the rot gene, a global gene regulator. However, 
a direct repressor of aur is SarA, the product of sarA, which binds the aur promoter (54, 82). 
 When the gene encoding aureolysin was characterized, it was revealed that the 
product would be about 509 amino acids in length, whereas the crystal structure of the 
protein revealed only 301 amino acids, suggesting that aureolysin undergoes post-
translational processing. The enzyme in its unprocessed form is expressed as a 56 kDa 
propeptide which undergoes autocatalysis resulting in the removal of a 23 kDa propeptide to 
yield the 33 kDa active mature enzyme (69). As seen with other members of the M4 family 
of metallopeptidases, aureolysin acts as a proprotein convertase and processes and activates 
other enzymes. The activity of this protease depends on both a zinc ion in the active site, as 
well as three calcium ions, and its activity is susceptible to the addition of metal ion chelators 
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such as EDTA. Aureolysin is required for the progression of the Staphylococcal proteolytic 
cascade, and inactivation of aureolysin results in a culture which lacks proteolytic activity 
(69). 
 Activation of the serine glutamyl endopeptidase is dependent on aureolysin, although 
it is necessary for proSspA to first undergo a series of initial autocatalytic steps in order for 
efficient final activation by aureolysin to occur. Autocatalyis is enabled by the presence of a 
glutamine rich region in the propeptide, and subsequent release of the mature enzyme occurs 
from cleavage at Leu56 followed by Val69 by aureolysin. The mature form of SspA is 
involved in the moderation of S. aureus adhesion to fibronectin, as it degrades cellsurface 
fibronectin binding proteins and consequently contributes to invasive infection (70). 
Furthermore, the mature SspA is also responsible for the activation of proSspB. 
 The final product of the staphylococcal proteolytic pathway is the mature form of the 
Staphopain B cysteine protease. It has been established that SspC helps to maintain the SspB 
precursor as an inactive zymogen (60). The activation of proSspB is dependent upon SspA 
cleavage of the C-terminal end of the propeptide of SspB. The mature SspB protease has a 
variety of roles, one of which is moderating the adhesive functions of the cell, and it has been 
shown to preferentially cleave fibronectin to release the N-terminal portion. 
 The proteases of S. aureus staphylococcal cascade contribute to the virulence of this 
pathogen by degrading plasma molecules, degrading molecules of the immune system 
enabling immune evasion, controlling adhesion, and activating other enzymes. 
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1.4 Lipases 
 
1.4.1 Microbial Lipases 
Lipases are enzymes found in animals, plants and microorganisms and have become 
important for industrial usage. They are a class of hydrolases and, more specifically, 
esterases which catalyze the hydrolysis of acylglycerol into glycerol and free fatty acids in a 
lipid-water interface. Lipases can also catalyze the hydrolysis and transesterification of other 
esters in addition to the synthesis of esters. Lipases are differentiated from esterases as they 
are capable of degrading both emulsions and monomeric substrate where esterases only 
degrade the latter (39). Thus lipase activity is dependent on the presence of an interface, such 
that lipases were further defined as carboxylesterases acting on emulsified substrates (39).  
Lipases can be classified into three groups, based on their substrate specificity. One 
group of lipases hydrolyses only the primary ester bond of a glyceride, although recently 
lipases with low activity towards hydrolyzing the second ester bond have also been 
discovered. Another group of lipases exhibit high preference for certain fatty acids, for 
example lipase B from Geotrichum candidum is specific for fatty acids with a double bond 
between C9 and C10 (85). However no bacterial lipase belongs to this group. The final group 
of lipases, which includes the lipases from S. aureus, have no positional or fatty acid 
specificity (39). Bacterial lipases vary greatly in size, and although the overall homology of 
lipases is relatively low, all share a similar three dimensional fold known as the α/β 
hydrolase, and the region of highest conservation is the active site containing a Ser-His-Asp 
catalytic triad (81). In most lipase structures, the active site is covered by surface loops and 
helical structures, making it inaccessible. The active site becomes exposed upon interaction 
with micelles and substrate molecules (81). 
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1.4.2 S. aureus Lipase 
Lipolytic activity in staphylococci was discovered as early as 1901. Lipolytic activity 
by S. aureus is known to release large amounts of fatty acids, for example linoleic acid in 
human plasma. The lipases responsible for these reactions are extracellular lipases which are 
secreted into the medium (32). The Glycerol Ester Hydrolase lipase of S. aureus, is secreted 
as a 72 kDa precursor enzyme (proGeh), which is then processed into mature 42 kDa form 
(Geh). Its function, as the name suggests is to catalyze the hydrolysis of the ester bonds 
between glycerol and fatty acids, which form triglycerides and this is believed to aid the 
bacteria by contributing to the breakdown of host tissue, subsequently liberating nutrients. 
The lipolytic activity of this lipase is sensitive to metal ion chelators such as EDTA, as the 
enzyme requires calcium to function (32).  
Geh has been implicated in virulence, and has been shown to interfere with the host 
granulocyte function, and increase survival of the bacteria against the host defense by 
inactivating bactericidal lipids (37). S. aureus strains recovered from deep infections show 
significantly more lipase activity than those obtained from superficial abscesses. 
Furthermore, during biofilm formation the lipase encoding genes were found to be induced 
and were found to be up-regulated during biofilm formation in S. aureus. Furthermore, lipase 
inhibitors have been shown to reduce biofilm formation in S. aureus. Additionally, mutation 
of the lipase genes results in reduced peritoneal abscess formation (37). Other than this, 
however, there has not been any significant research regarding the contribution of Geh to S. 
aureus virulence or colonization, especially in relation to persistence on human skin. 
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1.5 Rationale and Hypothesis 
 
The goal of this research was to elucidate a mechanism involving lipid metabolism in S. 
aureus. Previous research indicates that when grown in the presence of linoleic acid, the lag 
phase of growth of USA300 was severely prolonged. Additionally, robust induction of the 
Staphylococcal proteolytic cascade was also observed, resulting in processing of proGeh to 
Geh, due to the presumed proteolytic activity of aureolysin. As a result, we hypothesize that 
lipid metabolism is a key factor contributing to the persistence of USA300 on human skin and 
its dissemination within the community. The first objective of this study was to purify both 
proGeh and aureolysin, and confirm that aureolysin was required for the processing of 
proGeh. The second objective was to determine the effect of triglycerides on growth of 
USA300 and mutants deficient for proGeh (and consequently the mature Geh) and 
aureolysin. This was a follow-up on the multitude of events seen during growth in linoleic 
acid, including the effects on the proteolytic cascade, lipase maturation and overall growth. 
From these experiments it was determined that trilinolein resulted in an extended lag phase in 
wild-type and aureolysin deficient strains, and the lag phase was especially prolonged in 
aureolysin deficient strains. Conversely, trilinolein had no effect on Geh deficient strains. 
Since the aureolysin mutant, which produces only proGeh, had a longer lag phase than the 
wild-type, the third objective was to determine which factors caused the lag in growth and 
characterize their activity on trilinolein.  
 
 
 
 
22 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
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MATERIALS AND METHODS 
 
2.1 Bacterial strains and growth conditions 
 
The bacterial strains and plasmids used in this study are described in Table 2. MRSA 
isolate pulsed-field gel electrophoresis type USA300 LAC that had been cured of the 
erythromycin resistance plasmid was used in all experiments as the wild-type (WT) strain. 
Unless otherwise indicated, both E. coli and and S. aureus were cultured at 37°C and stored 
at -80°C in 20% glycerol. E. coli strains were grown in Luria Bertani (LB) medium. S. 
aureus strains were grown in tryptic soy broth (TSB). For strains carrying resistance genes, 
antibiotics were used at the following concentrations: chloramphenicol (10 μg/mL) and 
erythromycin (3 μg/mL) for growth of S. aureus strains; ampicillin (100 μg/mL) and 
kanamycin (40 μg/mL) for growth of E. coli strains. Solid media were obtained by the 
addition of 2% (w/v) Bactor agar (Difco). Water for preparation of growth media and 
solutions was obtained by passage through a Milli-Q water filtration system (Millipore 
Corp.). 
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Table 2. Strains used in this study 
 Strain or 
plasmid 
Description
a
 Source or reference 
 
    
Strains 
 
S. aureus 
 
USA300 LAC 
Community-acquired MRSA; WT strain, cured 
of resistance plasmid 
(2) 
RN4220 rK
- 
mK
+ 
; capable of accepting foreign DNA (49) 
H2660 USA300Δgeh This Study 
H2789 USA300Δaur::Erm; Ermr (2) 
   
RN6390ΔsarA RN6390ΔsarA (70) 
E. coli 
 
  
DH5α 
F
-ϕ80dlacZΔM15 recA1 endA1 gyrA96 thi-1 
hsdR17 (rK
− 
mK
+
) supE44 relA1 deoR 
Δ(lacZYA-argF)U169phoA 
Promega 
BL21 (DE3) E. coli B (DE3)[F
-
 dcm ompT hsDa (rB
-
 mB
-
)] (89) 
 
a Abbreviations: Ermr designates resistance to Erythromycin  
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2.2  DNA methodology 
 
2.2.1 Plasmid isolation from E. coli 
All plasmids used in this study are listed in Table 3. Plasmid DNA was prepared from 
E. coli using the E.Z.N.A. Plasmid Miniprep Kit (Omega Biotek) according to the 
manufacturer’s instructions. Briefly, approximately 5 mL of stationary phase culture of E. 
coli were pelleted via centrifugation and resuspended in 250 μL of SolutionI/RNase (50mM 
Tris, pH 8.0, 20 mM EDTA, 100 μg/mL of RNaseA). Cells were lysed by adding 250 μl of 
Solution II (200 mM NaOH, 1% (w/v) SDS), gently inverting the tubes followed by 
incubation at room temperature for 2-5 minutes. To neutralize the solution, 350 μl of 
Solution III (guanidine hydrochloride with acetic acid) was added to the lysate and was 
immediately inverted several times until a precipitate formed. The insoluble material was 
subsequently centrifuged for 10 minutes at 13000 rpm to form a pellet. The resulting cleared 
supernatant was aspirated into a HiBind DNA Miniprep Column (I) and was centrifuged at 
13000 rpm for 1 minute. 500 μl of Buffer HB was added to wash the column and ensure that 
residual protein contaminations are removed. 700 μl of DNA Wash Buffer diluted with 
absolute ethanol was added to the column and centrifuged for 1 minute at 13000 rpm. The 
column was subsequently centrifuged for 2 minutes at 13000 rpm to dry the column matrix. 
Plasmid DNA was then eluted from the column into a fresh microcentrifuge tube by addition 
of 30 μl to 100 μl of dH2O followed by centrifugation at 13000 rpm for 1 minute.  
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Table 3. Plasmids used in this study 
 
Plasmids Description
a
 Source 
pET28a(
+) 
T7 expression vector carrying N terminal 
His Tag/thrombin/T7 tag; Km
r
 
Novagen 
pVVgeh pET28a(+) containing geh; Km
r
 This Study 
 
a Abbreviations:  Kmr designates resistance to Kanamycin 
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2.2.2 Plasmid isolation from S. aureus 
Plasmid DNA isolation from S. aureus followed the same protocol as described for E. 
coli but with a few modifications. The harvested cells were incubated at 37°C for 30-60 
minutes in a 250 mL mixture of Solution I containing lystostaphin (Sigma) (1 mL Solution I 
added to 50 μg of lysostaphin) in lieu of RNase A solution, prior to addition of Solution II. 
 
2.2.3 Isolation of chromosomal DNA from S. aureus 
Chromosomal DNA was obtained from S. aureus by pelleting 500 μl of overnight 
stationary phase cells grown in TSB culture. 200 μl of STE (75 mM NaCl, 25 mM EDTA, 20 
mM Tris pH 7.5) was added to the cells along with 50 μg/ml of lysostaphin dissolved in 20 
μL of STE in order to facilitate cell lysis. The cell suspension was incubated at 37°C for 1 
hour. 20 μl of 10% SDS and 20 μl of Proteinase K (New England Biolabs) were added and 
incubated overnight at 55°C. Subsequently, 80 μl of 5M NaCl was added and mixed by 
inversion. 320 μl of a 25:24:1 phenol : chloroform : isoamyl alcohol (IAA) (Invitrogen) was 
added and was allowed to sit at room temperature for 30 minutes. The aqueous layer was 
removed after the mixture was spun at 12000 rpm for 10 minutes. Addition of 300 μl of 24:1 
chloroform:IAA was added and then the mixture wasspun at 12000 rpm for 10 minutes. The 
aqueous layer was subsequently removed, and 400 μl of isopropanol was added until the 
DNA formed a visible mass while gently inverting. The mixture was allowed to sit for 10 
minutes at room temperature, and was then spun at 12000 rpm for 5 minuts. The pellet was 
washed with 70% ethanol, dried, and resuspended in 100 μl of dH20. 
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2.2.4 Restriction Enzyme Digests 
Restriction enzymes were purchased from Life Technologies, MBI Fermentas, New 
England Biolabs, or Roche Diagnostics. Reactions were typically carried out in 30-40 μl 
volumes over a 1-2 hour incubation at the appropriate temperature (typically 37°C). Digested 
DNA was subsequently cleaned using a QIAquick PCR purification kit (QIAgen) as 
described by the manufacturer.   
 
2.2.5 DNA ligations 
DNA fragments were ligated in a 20 μl reaction volume using a 10:1 ratio of insert to 
vector DNA. Reactions were carried out using the T4 DNA ligase Rapid Ligation Kit (Roche 
Diagnostics) in accordance with the manufacturer’s recommendations. 
 
2.2.6 Agarose gel electrophoresis 
 Agarose gel electrophoresis was used for the separation and analysis of DNA 
fragments. Agarose gels (0.8% w/v) were prepared using 1X TAE buffer (40 mM Tris 
acetate, 1 mM EDTA) to which either 1.5 μg/ml of ethidium bromide of 2 μl of SYBR Safe 
DNA gel stain (Invitrogen) was added. DNA samples to be run were mixed with loading 
buffer (5% glycerol, 0.04% bromophenol blue, 0.04% xylene cyanol, 10 mM EDTA, pH 7.5) 
prior to being loaded in the gel. Electrophoresis was typically carried out at 110 V for 20-25 
minutes. The 1 kb-Plus ladder (Invitrogen) was used as a standard reference marker for 
estimation of DNA fragment size. Following electrophoresis, DNA fragments were 
visualized using a gel doc (Bio-Rad).  
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2.2.7 Isolation of DNA fragments from agarose gels 
Desired DNA fragments were visualized under long-wave UV light (365 nm) and 
excised from agarose gels following electrophoresis. DNA was isolated using the QIAquick 
Gel Extraction Kit (QIAGEN) using a protocol as described by the manufacturer.  
 
2.2.8 Polymerase chain reaction (PCR) 
 PCR reactions were carried out in 50 μl reactions containing: DNA template, 1x PCR 
buffer, 200 uM dNTP mix (Roche Diagnostics), 12 pM of forward and reverse primers, and 
0.5 units of Taq DNA polymerase. PCR reactions were also carried using KAPA HiFi 
HotStart PCR Kits (Kapa Biosystems). Briefly, 25 μl reactions containing template DNA, 1X 
Kapa HF Buffer (2.0 mM Mg 2+ at 1X), 300 μM of dNTPs, 300 nM each of forward and 
reverse primer and 0.5 units of KAPA HiFI HotStart DNA Polymerase. PCRs were 
performed using the GeneAmp  PCR system (Perkin Elmer), DNA engine Gradient Cycler 
(Bio-rad) or the MJ Mini Personal Thermal Cycler (Bio-rad). Oligonucleotide primers were 
obtained from Integrated DNA Technologies.  
 
2.2.9 DNA sequencing 
DNA sequencing was performed at the DNA Sequencing Facility of the Robarts 
Research Institute (London, Ontario, Canada), with sequencing reactions prepared according 
to their guidelines.  
 
2.2.10 Computer Analyses 
DNA sequence analysis, sequence alignments, and oligonucleotides primer design 
were carried out using Vector NTI Suite 7 software package (Informax, Inc., Bethesda, 
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Maryland). Blast searches were performed using tools available through the National Center 
for Biotechnology Information (http://www.ncbi.nlm.nih.gob/blast/). 
 
2.3 Transformation and transduction methodologies 
 
2.3.1 Preparation of transformation competent E. coli 
E. coli DH5a or E. coli BL21 DE3 CaCl2 competent cells were prepared as follows. 
An overnight, stationary phase culture of DH5a was diluted 1:100 into 500 ml of fresh LB 
and grown to an OD600 of approximately 0.5 and placed on ice for 30 minutes. The cells were 
then harvested via centrifugation and resuspended in 100 ml of ice cold 100 mM CaCl2 plus 
15% glycerol and incubated on ice for 30 minutes. Cells were again collected by 
centrifugation, resuspended in 4 ml of CaCl2 plus 15% glycerol, and stored as 100 μl aliquots 
at -80°C.  
 
2.3.2 Transformation of CaCl2 competent E. coli 
To transform CaCl2 competent E. coli DH5a or BL21, purified plasmid DNAor 
ligation mixtures were added to an aliquot of competent cells and kept on ice for 45 minutes, 
after which cells were subjected to a heat shock treatment at 42°C for 2 minutes immediately 
followed by a 2 minute incubation on ice. An 800-ul aliquot of LB broth was added to the 
tube, mixed, and the cells were permitted to recover for 1 hour at 37°C before being plated 
on selective media and incubated overnight. 
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2.3.3 Preparation of transformation competent S. aureus 
Strains of S. aureus were made competent for transformation via electroporation as 
follows. An overnight culture of S. aureus was diluted 1:100 into 100 mL of fresh TSB and 
grown to an OD600 of approximately 0.3. Cells were then harvested via centrifugation and 
resuspended in 500 mM sucrose. Cells were subsequently washed three times with ice cold 
500 mM sucrose. After the final wash, cells were resuspended in 1 mL of 500 mM sucrose 
and stored as 80 μl aliquots at -80°C.  
 
2.3.4 Transformation of electrocompetent S. aureus  
Electrocompetent S. aureus were transformed using purified plasmid DNA (typically 
5 μl from an EZNA miniprep). DNA was added to a tube of competent cells and allowed to 
incubate on ice for 30 minutes before being transferred to an ice-cold electroporation cuvette 
(2mm, Bio-Rad) for electroporation. Following incubation, electroporation was performed 
using a Bio-Rad Gene Pulser II with setting of 2.5 V, 200 mA, and 25 Ω. Ice cold TSB (800 
μl) was immediately added to pulsed cells, which were then recovered for a minimum of 1 
hours at 37°C before being plated on appropriate selective media.  
 
2.4 Mutagenesis and DNA cloning methods - mutagenesis of geh 
A S. aureus USA300 geh deletion mutant was constructed using the pKOR-1 plasmid 
(6). Sequences flanking the geh locus of USA300 FPR3757 were PCR amplified using 
specific primers (Table 4) to produce the upstream and downstream arms. A PCR amplicon 
of the joined DNA fragments was recombined into the temperature sensitive pKOR1 vector, 
resulting in the pKOR-1Δgeh plasmid. The resultant plasmid was first passaged through S. 
aureus RN4220 before being introduced into USA300 by electroporation. The in-frame  
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Table 4.  
 
 
 Oligonucleotides Descriptiona  
  
geh 5′F 
GGGGACAAGTTTGTACAAAAAAGCAGGCTAACA
TAGGGCATAAGTGGAC  
 
geh 5′R CGCTAACACTGACACCACG 
 
Generation of S. aureus geh allele, 5’ arm 
 
geh 3′F 
/5Phos/GGTATCTGGCAAGTTAAACC 
 
geh 3′R 
GGGGACCACTTTGTACAAGAAAGCTGGGTTTGCA
CAACTCACTTCACC 
 
Generation of S. aureus geh allele, 3’ arm 
 
geh 5′F-NdeI 
TTTTCATATGTTAAGAGGACAAG 
 
geh 3′R-EcoRI TTTGAATTCCAGCACGATTTACATAGC 
 Cloning of S. aureus geh 
 
a Restriction sites in sequences are underlined. 
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allelic replacement of the geh locus was achieved using the method previously 
described (6). The correct deletion of codons 25 to 631, of the geh gene, was confirmed by 
PCR and DNA sequence analysis. 
 
2.5 Protein methodology   
 
2.5.1 TCA Precipitation, and visualization of secreted proteins 
Proteins in the cell-free culture supernatant were precipitated by mixing supernatant 
with an equal volume of ice-cold 20% trichloroacetic acid, washed in ice cold 70% ethanol, 
then air dried and dissolved in SDS-PAGE reducing buffer (70). Density of the culture 
(OD600) was determined before preparation of cell-free culture supernatant, and for the 
analysis of secreted protein profiles, TCA precipitated protein derived from 5.0 OD600 units 
of culture was loaded into the lanes of an 12% acrylamide gel. The gels were stained with 
Coomassie Brilliant Blue R-250 to visualize the protein bands. 
 Protein bands were excised using an Ettan™ Spot Picker, and processed for mass 
spectrometry using a Waters MASSPrep Automated Digestor.  Processed protein samples 
were spotted on MALDI plates and analysis was done using an Applied Biosystems 4700 
Proteomics Analyzer. Data were acquired and processed using the 4000 Series Explorer and 
Data Explorer (Applied Biosystems), and using the MASCOT search engine, the peptide 
fingerprints were compared to the NCBInr database for Gram-positive bacteria. 
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2.5.2 Purification of Aur and Geh 
For purification of aureolysin, 1.5 liters of RN6390ΔsarA was grown overnight in 
TSB at 37°C in an orbital shaker, set at 200 rpm and the cell-free supernatant was collected. 
The supernatant was precipitated by adding ammonium sulphate up to 85% saturation. The 
precipitate was then resuspended in binding buffer (20 mM Tris-HCl pH 7.4, 5 mM CaCl2) 
and loaded on a sepharose packed 5 mL HiTrap column equilibrated with binding buffer. The 
protein was eluted over a gradient of 0%-80% elution buffer (20 mM Tris pH 7.4, 500 mM 
NaCl, 5 mM CaCl2). Protein fractions were collected and dialysed against 20 mM Tris pH 
7.4 with 5 mM CaCl2. Protein purity was confirmed using SDS-PAGE, and protease activity 
was confirmed with a protease assay (described above). 
 The full length of the gene encoding Geh was PCR-amplified from S. aureus strain 
USA300 using forward and reverse primers containing NdeI and EcoRI restriction sites, 
respectively. The amplicon was digested with NdeI and EcoRI and cloned into NdeI-EcoRI-
digested pET28a(+) (Novagen), which incorporates a thrombin-cleavable His6 tag at the N-
terminus of the encoded recombinant protein. The pVVgeh (pET28 with Geh) construct was 
introduced into E. coli BL21 (DE3). Cells were grown in LB media containing 50 μg/mL 
kanamycin at 37°C in an orbital shaker, set at 200 rpm. When the culture reached an OD600 of 
0.6, isopropyl β-D-1-thiogalactopyranoside was added to a concentration of 0.5 mM. The 
culture was further incubated for another 16 hours at 25°C, after which cells were collected 
via centrifugation. The cell pellet was re-suspended in 30 mL Buffer A (10 mM Tris-HCl pH 
8.0, 300 mM NaCl, 10 mM imidazole). The cells were lysed using a cell disrupter (Constant 
Systems Inc.) at 30 psi after which 10 μM E64, a cysteine protease inhibitor, was added to 
the lysate, and further cell debris was removed by centrifugation (3000 rpm for 15 minutes). 
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Any remaining cellular debris was removed by ultracentrifugation (50000 rpm for 60 
minutes) and the soluble lysate was applied to a nickel-loaded 1-ml HisTrap column (GE 
Healthcare) equilibrated with buffer A. The His6-tagged protein was eluted from the column 
with a gradient of 0%–80% buffer B (10 mM Tris-HCl pH 8.0, 300 mM NaCl, 500 mM 
imidazole) using an ÄKTA FPLC (GE Healthcare). Protein fractions were collected and 
dialysed against 10 mM Tris pH 8.0. Protein purity was confirmed using SDS-PAGE. Lipase 
activity was confirmed using the pNPP based assay as described previously (34) and the 
protein was quantified using a Bradford Assay. 
 
2.6 Assays 
 
2.6.1 Lipase Assay  
Lipase activity was assayed with para-nitrophenyl palmitate (pNPP) substrate 
(Sigma). For assessment of lipase activity in cell-free supernatants, cultures were grown for 
18 hours and filtered across a 0.22 micron filter. Supernatant was concentrated using Amicon 
10 K centrifugal filters by centrifugation for 30 minutes 3000 rpm. Prior to assay, the 
supernatant samples were normalized by dilution with sterile water as needed, to adjust for 
minor differences in cell density of the stationary phase cultures at time of harvest.  Solution 
A (795 μM pNPP substrate in isopropanol) was added to solution B (0.005 % Triton X-100, 
50 mM Tris-HCl pH 8.0, 1 mg/mL gum arabic) at a 1:9 ratio. Aliquots of the normalized 
supernatant were added to the assay buffer (Solution A and B). For measurement of activity 
of purified proGeh or mature Geh (as described previously), aliquots of enzyme were added 
to the assay buffer. Samples were incubated for 30 minutes at 37°C in the dark and 
absorbance was quantified at 410 nm using a Varian Cary 50 spectrophotometer. 
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2.6.2 Protease assay  
Total protease activity of culture supernatants, as well as purified aureolysin, was 
assayed with FITC-casein substrate (Sigma). Before the assay, the supernatant samples were 
normalized by dilution with sterile water to adjust for minor differences in cell density of the 
stationary phase cultures at time of harvest. For purified aureolysin, aliquots of the protease 
were mixed in sterile water to a volume of 490 μL. These samples were mixed with 460 μL 
of incubation buffer (40 mM Tris-HCl pH 7.4, 300 mM NaCl, 20 mM CaCl2, and 2 mM L-
cysteine) and 50 μL of 0.2% w/v FITC-casein. EDTA was used as an aureolysin inhibitor. 
The samples were incubated at 37°C for 2 h in the dark. Trichloroacetic acid was then added 
to 4% w/v to stop the reaction, and the samples were centrifuged at 15000 rpm for 15 
minutes to pellet undigested casein. The supernatant was then mixed with an equal volume of 
0.5 M Tris-HCl, pH 8.5, and after transfer to Optilux black clear bottom microtitre plates 
(BD Falcon), fluorescence was quantified on a Biotech plate reader using excitation at 485 
nm and emission at 535 nm. 
 
2.6.3 Aureolysin-Geh processing 
The rate of Geh processing by aureolysin was determined to optimize the minimum 
quantity of aureolysin required to produce mature Geh.  Briefly, 3 μg of Geh was first 
incubated at 37°C for 3 hours in lipase buffer (50 mM Tris HCl pH 8.0) containing varying 
amounts (1 - 0.001 μg) of aureolysin. Additionally, a suitable time frame for the reaction was 
determined by incubation of 3 μg of Geh at 37°C in lipase buffer (50 mM Tris HCl pH 8.0) 
with 0.01 μg of aureolysin. Samples were removed from the incubator at varying time points 
(5-90 minutes). Reactions were stopped with the addition of SDS-PAGE reducing buffer, 
37 
 
 
 
followed by heating for 5 minutes at 95°C. Assessments of the levels of proGeh and mature 
Geh were made visually following SDS-PAGE. 
 
2.7 Influence of triglycerides on S. aureus growth  
Trilinolein was purchased from TCI America. Prior to supplementing TSB media, the 
triglyceride was first mixed with an equal volume of DMSO, and then diluted in TSB to a 
working stock concentration of 5 mM.  Cell-free supernatant was obtained from cultures 
grown for 18 hours in 25 mL volume TSB at 37°C on an orbital shaker incubator. Purified 
proGeh was prepared by incubation at 37°C in lipase buffer (50 mM Tris HCl pH 8.0) 
whereas mature Geh was prepared by incubation of proGeh with aureolysin (0.002 μg) in 
lipase buffer for 3 hours at 37°C. Washed cells were prepared by removing the cell free 
supernatant from precultured cells, and washed in saline twice before re-suspension in fresh 
TSB media. 
For growth analyses, bacteria from single colonies on TSB agar were inoculated into 
culture tubes containing 5 mL of antibiotic free TSB, and grown overnight at 37°C on an 
orbital shaker, followed by measurement of OD600. A 25-mL volume of TSB, supplemented 
with triglyceride, supernatant (100 μL) and/or purified protein (2.7 μg) , was then inoculated 
to achieve a starting OD600 of 0.01, and the cultures were grown at 37°C on an orbital shaker 
incubator, set at 200 rpm. Measurements of OD600 were taken at set time points. All growth 
analyses were conducted in at least triplicate, from individual cultures. 
 
2.8 Lipid extraction and analysis by GC/MS 
The substrate trilinolein was tested against the two forms of Geh, proGeh and mature 
Geh. For analysis of proGeh, 3 μg of proGeh was incubated in lipase buffer (50 mM Tris-
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HCL pH 8.0) for 3 hours at 37°C. To obtain mature Geh, 3 μg of proGeh was incubated in 
lipase buffer (50 mM Tris-HCL pH 8.0) with 0.002 μg of aureolysin for 3 hours at 37°C. Post 
incubation, trilinolein was added to a final concentration of 5 μM in a total 50 μL final 
reaction volume and incubated at 37°C for 60 minutes. 
 Fatty acids were then extracted two consecutive times with 500 L of hexane, and the 
hexane extracts were then pooled together and dried under a constant stream of nitrogen gas. 
Dried samples were trimethylsilylated with 50 L of pyridine and 50 L of, 
Obis(trimethylsilyl)trifluoroacetamide (BSFTA) + 1% Trimethylchlorosilane (TMS) 
(Sigma), and incubated at 70°C for 40 minutes. 
 Fatty acids were chromatographed as their TMS-esters on an Agilent 7890 GC 
equipped with a CP-Sil 5 column (0.25 mm x 30 m) and a flame ionization detector (FID). 
Samples (1 µL) were injected in splitless mode onto the column and eluted with a 
temperature gradient as follows: initial temp. 80°C held for 2 min, followed by a ramp up to 
220°C (40°C/min) and then a ramp up to 300°C (15°C/min). The final temperature was held 
for 4.2 min for a total run time of 15 min. Nitrogen (N2) was used as a carrier gas at 2.0 
mL/min. The injector and FID temperatures were 270°C and 300°C, respectively. 
 
 
 
  
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
  
40 
 
 
 
RESULTS 
 
3.1 Deletion of the geh locus 
 As stated previously, our laboratories' previous work showed that unsaturated fatty 
acids, including linoleic acid, induced robust expression of the proteolytic cascade. One 
result of this was the processing of proGeh (pro glycerol ester hydrolase; lipase; 
SAUSA300_0320) to its mature form. One of the main goals of this study was to determine 
if this processing had any role to play in the biological response of S. aureus to the presence 
of fatty acids. The geh gene is 2, 073 bp and encodes a protein containing 690 amino acids 
with a molecular mass of 72 kDa.  In order to assess the importance of Geh during growth in 
the presence of antimicrobial lipids, a geh in-frame deletion was constructed as described in 
the Materials and Methods section. PCR amplification across the geh locus of wildtype and 
mutant confirmed the deletion in the mutant strain (Figure 4).  
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Figure 4. Generation of a Δgeh mutant in S. aureus strain USA300. PCR amplification 
across the geh open reading frame confirms the deletion in the mutant strain.  The PCR 
amplicon was sequenced for final confirmation.  Strain H2660 is the number given to the 
Δgeh mutant.  
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3.2 Growth in fatty acid results in processing of Geh 
 As stated above, previously, our laboratories showed that when grown in 50 μM 
linoleic acid, USA300 exhibited an extended lag phase in addition to the robust expression of 
the staphylococcal proteolytic cascade (2). This proteolytic cascade begins with the 
expression of the metalloprotease aureolysin and culminates with the activation of the 
cysteine protease SspB. Additionally under these conditions, the 72 kDa precursor form of 
Geh is processed into its mature 42 kDa form, but this processing is absent in an aureolysin 
mutant (2). The previous data was shown using MS to identify proteins of interest. We 
confirmed this phenotype and, using the geh and aur mutants, proved that indeed Geh was 
the protein being processed in an Aur-dependent fashion (Figure 5). Moreover, when we 
followed the kinetics of growth in the presence of linoleic acid, both the USA300Δgeh 
mutant and the USA300Δaur mutant displayed the same 12 hour lag period as wild type 
USA300 (data not shown), indicating that neither geh nor aur are required for growth in 
inhibitory concentrations of linoleic acid, nor are they directly responsible for the delay in 
growth in response to linoleic acid. 
 
3.3 Purification of Aur and Geh, and confirmation of their activity 
In a mutant lacking the aur gene, proGeh is among several proteins which remain 
unprocessed, as they require the proteolytic activity of the metalloprotease aureolysin. 
aureolysin is a zinc and calcium ion-dependent metalloprotease which initiates the 
staphylococcal proteolytic cascade. Therefore, to conduct a detailed analyses of the role of 
Aureolysin in processing of proGeh, we first needed to purify the two enzymes. As 
previously published by the McGavin laboratory (70), Aur was purified from the supernatant  
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Figure 5. Induction of Aur by linoleic acid results in processing of proGeh to Geh in S. 
aureus culture supernatants. SDS-PAGE of the culture supernatants of wild type and 
mutant USA300 strains grown in TSB or TSB supplemented with 50 μM linoleic acid for 18 
hours. Proteins in the cell free culture supernatant were precipitated in ice-cold TCA, and 
after solubilization in SDS-PAGE reducing buffer, protein equivalent to 3.5 OD600 units of 
culture supernatant was loaded in each lane.  Note that while the cultures grown in the 
presence of LA took longer to reach stationary phase, the cultures eventually reach the 
equivalent biomass as those grown in the absence of LA. 
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of an RN6390ΔsarA strain, a strain which overexpresses Aur in the culture supernatant, due 
to inactivation of sarA, which is a repressor of protease expression.  
Aur was purified as described in the Materials and Methods (Figure 6A) and activity was 
confirmed using a FitC-labeled casein substrate, Figure 6B, where cleavage of the casein by 
Aur results in a measureable increase in fluorescence. 
 Next a recombinant geh was cloned into the pET28a vector and overexpressed and 
purified from E. coli BL21 by passage through a nickel affinity column. The purified protein 
runs at 72 kDa in an SDS-PAGE gel, although numerous other bands were also observed 
(Figure 6). These were confirmed via mass spectrometry to be degradation products of 
proGeh, in addition to small quantities of the mature 42 kDa Geh. After several attempts to 
obtain highly purified 72 kDa proGeh, we concluded that the protein was simply prone to 
degradation, as has been observed previously (86), such that the small number of degradation 
products present were not going to be easily removed.  
 Processing of proGeh by aureolysin was determined by incubation of the two proteins 
for various times, as well as at several ratios of Aur to proGeh. The samples were then 
visualized on SDS-PAGE gels for the presence of the 38 kDa Aur band, the disappearance of 
the 72 kDa proGeh band and an increasing abundance of the 42-kDa band representing 
mature Geh (Figure 7). The result showed that Aur is highly active on proGeh, with only 
0.01 μg of aureolysin being needed for complete processing of 3 μg of proGeh in 30 minutes. 
Furthermore, the addition of metal ion chelators such as EDTA inhibit the activity of the 
metalloprotease Aur, as expected, resulting in loss of activity on FITC-casein (Figure 6B) 
and on proGeh (data not shown).  
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B 
 
Figure 6. Purification of Aur and proGeh. A) SDS-PAGE showing purified aureolysin (38 
kDa) and purified proGeh (72 kDa). 3 μg of protein were added to each lane. Lack of 
stability of proGeh enzyme resulted in a mixture of degradation products of various sizes, 
including the mature 42 kDa Geh, during the purification steps. B) Protease assay using FitC-
labeled casein as a substrate for Aur. EDTA, which chelates metal ions such as Zn
+
 and Ca
2+
 
which are required for functional Aur, was added to the Aur sample where indicated. Data is 
reported as fluorescence emission at 535 nm measured in arbitrary fluorescence units.  
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Figure 7. Visualization of proGeh processing by Aur. SDS-PAGE gel showing processing 
of Geh by Aur. Lanes 1 and 2 contain 3 μg of pure Aur and proGeh, respectively. Lanes 3-7 
contain 3 μg of pure Geh incubated with ratios of pure Aur:proGeh, as indicated, for 30 
minutes at 37°C. The reaction was stopped with the addition of SDS-PAGE buffer followed 
by heating the samples at 95°C. 
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3.4 The USA300 geh mutant has no detectable lipase activity 
 In addition to geh, other putative lipase genes exist within S. aureus USA300, 
including lip and the putative lysophospholipases SAUSA300_1194 and its homologue 
SAUSA300_0070 encoded on the ACME cassette. However, the function of these genes and 
their products are not well characterized.  The lip gene encodes a putative triacylglycerol 
lipase; however this gene has not yet been characterized in the literature. The presence of 
SAUSA300_0070 on the ACME cassette suggests it may have a function in skin colonization 
as do some of the other genes present in the ACME cassette, such as speG, and the arc genes. 
 In order to determine which of these lipases was needed for lipase activity in S. 
aureus we used a para-nitrophenyl palmitate (pNPP) substrate-based colourimetric assay 
(34). In pNPP, palmitate (C16:0) a saturated long chain fatty acid, is esterified to a para-
nitrophenol. The enzymatic hydrolysis of the ester bond between the fatty acid from para-
nitrophenol results in the liberation of the para-nitrophenol group which can be measured 
colourimetrically at 410 nm.  
 To determine whether geh was required for lipase activity, the supernatants of the 
Δgeh and Δaur mutants were analyzed using the pNPP lipase assay. The wild type 
supernatant contained both proGeh and mature Geh, while the supernatant from the Δaur 
strain possessed only proGeh, and the Δgeh contained neither.  As shown in Figure 8A, the 
most activity is seen in the supernatant of the Δaur mutant while the supernatant of the Δgeh 
mutant was completely devoid of any measureable para-nitrophenol. The higher level of 
lipase activity measured in the Δaur strain may be caused by a variety of effects including 
potential upregulation of proGeh production in this mutant or due to the proGeh having a 
higher substrate preference for pNPP than mature Geh. To rule out the latter possibility, 
using the pNPP assay we also showed that both purified proGeh and Geh possess similar 
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B 
 
Figure 8. pNPP lipase assay of culture supernatants and purified Geh. Lipase activity 
was assayed from culture supernatants of USA300 isogenic mutants grown for 18 hours in 
TSB (A), and from both purified proGeh and Geh (B). For testing lipase activity in culture 
supernatants, OD600 0.2 unit equivalents of cultures supernatant was used. For pure proteins, 
0.9 μg of protein was used. 
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levels of lipase activity on pNPP as a substrate (Figure 8B). Therefore we conclude that both 
proGeh and Geh have similar activities on a saturated long chain fatty acid ester (palmitate) 
and that lipase activity in USA300 is dependent on the presence of geh.  
 
3.5 Growth in trilinolein results in inhibition of growth  
 The literature suggests that substantial quantities of unsaturated triglycerides are 
produced in abscesses (22, 84). Since 50 μM free linoleic acid caused a 12 hour lag phase, 
and as triglycerides are the major substrate for lipases, we opted to observe the effects on 
growth in trilinolein, a triacylglycerol composed of three linoleic acid molecules esterified to 
glycerol. A 50 μM concentration of trilinolein was chosen, since it was theorized that even if 
one free fatty acid was released from each molecule of trilinolein, it would result in a 
concentration of free fatty acid that would delay the growth of USA300.   
 To assess the role of a long chain unsaturated triglyceride, such as trilinolein on the 
growth of USA300, 50 μM of trilinolein was added to cultures in TSB. In TSB, USA300 
typically takes about 7-8 hours incubation at 37°C to reach stationary phase from a starting 
inoculum of  OD600 0.01.  However, in the presence of trilinolein the wild-type USA300 had 
a 6 hour extended lag phase and stationary phase was reached about 12-14 hours from 
inoculation (Figure 9). In contrast, the Δgeh mutant, which possesses no active lipases (see 
above) showed no such growth delay. In stark contrast to that result, the aureolysin mutant, in 
which there is an excess of proGeh due to lack of Aur for maturation into Geh, shows a very 
long lag phase lasting 10-12 hours and reaching stationary phase at around 18 hours from 
inoculation. The results suggest that Geh or some factor in the supernatant dependent on Geh 
activity, or a combination of both was likely involved in the breakdown of trilinolein, leading 
to the liberation of linoleic acid, and ultimately causing a delay in growth. Initially, the  
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Figure 9. Grow curve analysis of USA300 wild-type, Δgeh and Δaur with trilinolein. 
During growth in trilinolein (50 μM), a USA300Δgeh mutant grows without delay, however 
the wild-type strain exhibits an extended lag phase. The USA300Δaur mutant produces and 
an even longer lag phase than the wild-type. Cultures were grown in triplicate in flasks 
containing 25 mL TSB and trilinolein (50 μM). Cultures were inoculated to a starting OD600 
of 0.01. Y-axis, OD600; X-axis, growth time (hours). Error bars represent the Standard Error 
of the Mean. N=6, * p<0.05 for USA300 vs. USA300Δgeh, ** p<0.01 for USA300 vs. 
USA300Δgeh, *** p<0.001 for USA300 vs. USA300Δgeh, + p<0.05 for USA300 vs. 
USA300Δaur, ++ p<0.01 for USA300 vs. USA300Δaur, +++ p<0.001 for USA300 vs. 
USA300Δaur. 
 
51 
 
 
 
increased lag phase observed in the Δaur mutant suggested that the proGeh, which 
accumulates in this mutant, was more active on trilinolein compared to mature Geh. To 
determine the secreted protein profile of these strains, samples were grown in sub-inhibitory 
concentration of trilinolein (25 μM) and the cell-free supernatant was TCA precipitated and 
visualized by SDS-PAGE (Figure 10). Analysis of secreted proteins of these strains indicates 
that Geh is secreted and processed in the wild-type and confirms the lack of Geh in either 
form in the Δgeh strain. It further showed us that the Δaur mutant produced very minute 
amounts of proGeh. It is possible that Geh, in addition to some other factor in the supernatant 
is required for optimal growth in trilinolein. 
 
3.6 Aureolysin is required for optimal growth in Trilinolein 
 We were interested to elucidate the mechanism for why the aur mutant displayed a 
prolonged growth delay in the presence of trilinolein. We first decided to determine whether 
it was the result of a factor that was on the cell surface or whether it was found in the 
supernatant. Cells from the pre-culture were pelleted and the supernatant removed. These 
cells were then washed with saline to ensure any cell surface bound proteins were removed. 
A SDS-PAGE of unwashed and washed cells showed no difference in the protein profiles 
(Figure 11). Washed cells were then inoculated into TSB containing trilinolein and the 
resultant growth curve can be seen in Figure 11B. Washed wild-type and Δaur cells grow at 
the same rate as the Δgeh strain and showed no extended lag phase. This suggests that the 
factor implicated in causing the growth lag was present in the supernatant and not cell-
surface associated.  
 Since the Δgeh mutant showed no lag during growth in trilinolein, we wanted to 
determine the factor in the supernatant that caused the lag. To do this, Δgeh preculture cells 
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Figure 10. Secreted protein profile of cells grown in 50 M trilinolein. SDS-PAGE of the 
culture supernatants of wild type and mutant USA300 strains grown in TSB or TSB 
supplemented with 25 M trilinolein for 18 hours. Proteins in the cell free culture 
supernatant were precipitated in ice-cold TCA, and after solubilization in SDS-PAGE 
reducing buffer, protein equivalent to 5.0 OD600 units was loaded in each lane. 
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A 
 
B 
 
Figure 11. Comparison of cell-surface proteins of washed and unwashed cells and 
growth of washed cells in trilinolein. A) SDS-PAGE of cell surface proteins of USA300 
strains grown in TSB for 18 hours. Samples were standardized to OD600 2.0 of cells. 
Unwashed cells were pelleted and re-suspended in SDS-PAGE buffer while washed cells 
were first washed with saline before being re-suspended in SDS-PAGE buffer. Cells were 
then boiled and pelleted and the sample above the pellet was loaded in the gel. B) Pre-
cultured cells from all strains washed before inoculation into TSB containing trilinolein grow 
without an extended lag phase. 
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were pelleted and their supernatants were removed. The cell pellet was then re-suspended in 
cell-free supernatant of a wild-type or Δaur culture grown to stationary phase in TSB before 
being inoculated into TSB media containing trilinolein. As seen in Figure 12, both the wild-
type and Δaur supernatant induced an extended growth lag in the Δgeh strain, where none 
was previously observed. This confirmed the presence of a factor in these supernatants, 
which was responsible for the growth lag. Furthermore, fractionation of the wild-type 
supernatant using a 30 kDa amicon centrifugation filter, allowed us to determine that the 
factor in question was greater than 30 kDa, as cells re-suspended in the supernatant filtrate 
(molecules < 30kDa) showed no growth lag, in contrast to the lag observed in cultures 
inoculated with cells re-suspended in media containing a small amount of the retentate 
(molecules>30 kDa) (Figure 12). 
 Based on this we surmised that proGeh/Geh was the factor or one of the factors 
responsible for the extended lag phase, likely due to processing of trilinolein resulting in the 
liberation of linoleic acid. To confirm this, at the time of inoculation we added a small 
amount of purified proGeh and Geh to Δgeh cultures inoculated into TSB containing 50 μM 
trilinolein and, as expected, an extended lag phase occurred (Figure 13). This suggests that 
Geh is at least in part responsible for the extended lag phase observed in trilinolein. 
Additionally, the longer lag phase observed in the Δaur strain compared to wild-type 
USA300 suggests that aureolysin is required for optimal growth in the presence of trilinolein. 
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Figure 12. Delayed growth of Δgeh strain in trilinolein after re-suspension in 
supernatant from wild-type and Δaur.  USA300Δgeh mutant experiences a delayed lag 
phase in 50 μM trilinolein when cells are re-suspended in supernatant from other strains as 
indicated. OD600 0.01 of cells were inoculated into 25 mLs of media with 100 μL of 
supernatant from the indicated strains. 
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Figure 13. Impaired growth of Δgeh in trilinolein with addition of purified proGeh or 
Geh at inoculation. USA300Δgeh mutant incurs a delayed lag when purified proGeh or 
mature Geh are added during inoculation. OD600 0.01 of cells were inoculated with 1 μg 
proGeh or Geh and 0.002 μg Aur. 
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3.7 Gas chromatography confirms that trilinolein is a substrate for proGeh and Geh 
 Gas chromatography was used to confirm if both proGeh and Geh could release free 
linoleic acid from trilinolein.. The trilinolein was added to a mixture containing purified 
proGeh or mature Geh. The lipid fraction was extracted and analyzed using gas 
chromatography. The results revealed that trilinolein was processed by both proGeh and Geh 
resulting in the production of linoleic acid, seen as the peak occurring around 7.7 minutes 
(Figure 14).  
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Figure 14. Gas chromatography-mass spectrometry confirms release of linoleic acid 
from trilinolein by both forms of Geh. Gas chromatography of purified proGeh and Geh 
incubated with trilinolein. The production of linoleic acid (7.7 minutes) was used as a 
determinant of lipolytic activity. 
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CHAPTER 4 
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DISCUSSION 
 The superior transmissibility and colonization ability of the USA300 strain in 
addition to its ability to survive within the host make it one of the most successful human 
pathogens. Several mechanisms of innate immunity exist, preventing pathogens such as S. 
aureus from establishing an infection. One of the mechanisms of innate defense is the 
presence of anti-microbial fatty acids and lipids due to the secretion of sebum on the skin and 
lipid production in wound environments (22, 55, 65, 98).  Several free fatty acids such as 
palmitoleic acid (C16:1Δ9), sapienic acid (C16:1Δ6) and linoleic acid are capable of 
inhibiting the growth of S. aureus, and have been shown to produce an extended lag during 
growth and induce the robust expression of the staphylococcal proteolytic cascade (2).  
As reviewed within the introduction, previous research suggested that aureolysin, a 
zinc and calcium dependent secreted metalloprotease which initiates the staphylococcal 
proteolytic cascade, processed the maturation of proGeh (72kDa), the lipase of S. aureus, 
into the mature Geh (42 kDa) (2). Arsic et al. reported that this accumulation of proGeh was 
not present in a USA300ΔsspABC strain but was observed in a Δaur strain (2). When the 
secreted protein profile of the Δaur mutant was compared to that from a wild-type USA300, 
the accumulation of proGeh was very apparent. We further confirmed this function of 
aureolysin using purified aureolysin and proGeh. However, we found that obtaining pure 
proGeh proved difficult as the protein was prone to degradation, and as a result multiple 
degradation products, as confirmed by mass spectrometry, can be seen in Figure 6. The 
production of only mature Geh upon incubation of proGeh with aureolysin confirmed that 
aureolysin was responsible for the processing of Geh. Additionally, an aureolysin titering 
assay indicates that aureolysin has very high activity on proGeh, even when the amount of 
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proGeh to aureolysin was titred to 1:1500. However, the purpose for the processing of the 
lipase has yet to be determined. 
 The exact role and importance of Geh in S. aureus has not been determined, but there 
is some literature attempting to characterize this enzyme. However,  part of the reason for the 
lack of data on proGeh is due to difficulty with purification of this form. What can be taken 
from the literature is that Geh is a calcium dependent lipase, which has optimal activity at the 
higher pH ranges of 8.0-9.0, (21, 32). In addition to geh however, USA300 possesses other 
putative lipase genes such as lip and the putative lysophospholipases 0070 and 1194. Using a 
pNPP assay, we found that in USA300, deletion of geh resulted in a lack of detectable lipase 
activity, indicating that these genes do not directly contribute to secreted lipase activity.  
S. aureus encounters a large range of lipids both during skin colonization and during 
deep tissue infections. In staphylococcal abscesses, the production of neutral lipids is highly 
up-regulated (23). This includes triglycerides such as tripalmitolein, triolein and trilinolein. 
Previous studies have shown that when staphylococcal abscess homogenates are mixed with 
culture filtrate, there is a reduction in the quantity of triglycerides and a consequent increase 
in free fatty acids. Additionally, these activated culture homogenates had increased 
staphylocidal activity and implicated the presence of a secreted lipase for this activation. 
Furthermore, leucocyte lipases are also believed to contribute to the liberation of free fatty 
acid within abscess environments (21-23). We assessed the growth of a strain which could 
only produce the proGeh (Δaur) and a strain deficient for both forms of the enzyme (Δgeh) in 
the presence of the long chain unsaturated triglyceride, trilinolein. The cause of this 
phenotype could have been that only strains containing geh produced an extended lag phase 
due to the hydrolysis of trilinolein by Geh, resulting in the release of growth inhibitory 
linoleic acid.  
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However we needed to confirm that the factor responsible for growth lag we observed 
was present in the supernatant instead on the cell surface. Removal of the cell-free 
supernatant followed by washing cells before they were sub-cultured abolished the lag 
phenotype seen in wild-type and Δaur strains during growth in trilinolein. This, in 
combination with a lack of a difference between the protein profiles of cell surface associated 
proteins of washed and unwashed cells, suggests that the culprit responsible for the lag 
phenotype is present in the supernatant, in agreement with the possibility that Geh is 
responsible for the liberation of linoleic acid from trilinolein. 
The growth lag seen in the wild-type and Δaur strains could be replicated in the Δgeh 
mutant if cell-free culture supernatant from the wild-type or Δaur strain was added to the 
media containing trilinolein at the time of inoculation. When the wild-type supernatant was 
separated into retentate and filtrate fractions, the lack of the extended lag phase due to 
addition of the filtrate fraction meant that the molecule causing the extended lag was greater 
than 30 kDa, increasing the likelihood that either proGeh or Geh were the culprits in 
question. The extended lag phase observed when either purified proGeh or Geh was added to 
a Δgeh culture during inoculation confirmed that these lipases were indeed capable of 
causing an extended lag when grown in trilinolein (see Figure 13). 
The presence of lipase activity in Δaur supernatant as shown by the pNPP assay 
indicated that the unprocessed form of Geh had lipase activity. Interestingly the addition of 
proGeh to Δgeh cultures in trilinolein produced a longer lag phase than when only the 
processed enzyme was added. In addition to this, the lag phase observed in the Δaur mutant, 
that is incapable of processing proGeh or inducing the Staphylococcal proteolytic cascade, 
was nearly twice as long as that observed in the wild-type strain. This lead to the possibility 
that proGeh and mature Geh could have different substrate specificities, more specifically 
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that trilinolein was a substrate for proGeh but not Geh. Furthermore, the literature suggests 
that the mature form of S. aureus lipase, in contrast to traditional lipases which preferentially 
cleave long chain triglycerides, was shown to be more active on short to medium chain 
triglycerides such as tributyrin (86). This further supported the notion that the two forms of 
Geh could have differential substrate specificities.  
Gas chromatography was used to confirm the activity of Geh on trilinolein, and to 
confirm whether the different forms of the enzyme bound to different substrates. While the 
gas chromatography confirmed that linoleic acid was produced when proGeh and Geh were 
incubated with trilinolein, it also showed no significant difference between either forms of 
the lipase for trilinolein.  However, before concrete conclusions can be drawn from these 
studies, these experiments need to be performed again in an effort to make them as 
quantitative as possible.  
The secretion of Geh into an environment containing triglycerides is paradoxical if it 
results in the release of growth inhibitory free fatty acids, which add to the already existing 
pool of these compounds on the skin or in a wound environment. It is unlikely that S. aureus 
would have evolved to maintain conserved expression of Geh, if it did not confer a 
substantial benefit, and S. aureus does not have the metabolic capacity to generate energy 
through -oxidation of fatty acids (72). Recall that one of the predicted mechanisms of 
resistance to free fatty acids is the existence of the fatty acid modifying enzyme (FAME) 
which is believed to esterify free fatty acids to primary and secondary alcohols or cholesterol 
to form fatty acid esters. In fact 80% of staphylococcal strains which produce lipase were 
also found to produce FAME (57). Interestingly, FAME is strongly inhibited by long chain 
unsaturated triglycerides and, thus, Geh may work in concert with FAME to alter the lipid 
composition of the bacterial environment (55). 
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The 3 hour longer duration of the extended lag phase of cultures containing Δaur 
supernatant cultured in trilinolein compared to cultures containing wild-type supernatant, in 
addition to the longer lag phase observed in Δaur strains than in wild-type strains, indicates 
that aureolysin is also required for optimal growth in trilinolein. Since autocatalysis and 
activation of aureolysin is required for the subsequent and step-wise initiation of the 
Staphylococcal proteolytic cascade, a mutant unable to express aureolysin is likely to suffer 
from pleiotropic effects. This is because aureolysin is involved in the cleavage of several cell 
surface associated factors in addition to activation of zymogens including itself, proGeh and 
SspA. Additionally, a trickle-down effect due to lack of processing of SspA and SspB 
protease substrates would also occur causing several possible phenotypes.  
In summary, we confirm that Geh is required for lipase activity in S. aureus strain 
USA300 and that both the precursor and mature forms of Geh are capable of processing long 
chain unsaturated triglycerides, such as trilinolein, that are present in the skin and within 
wounds. Additionally further characterization of both proGeh and Geh substrate specificities 
on acylglycerols of various chain lengths and saturation can be determined by gas 
chromatography. Degradation products of these reactions, including the products from 
trilinolein can also be assessed to determine whether this lipase has positional and fatty acid 
chain length specificity. Moreover, in the presence of triglycerides we conclude that 
aureolysin is required for optimal growth and future work can focus on the mechanism by 
which lipid metabolism is regulated by the synergistic activity of these enzymes and how 
they facilitate survival of USA300 in wound environments and during colonization.  
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